中信建投-信达生物(01801.HK)Innovent Biologics partners with Pfizer to further upgrade globalization-260602

登录忘记密码注册

>> 中信建投-信达生物(01801.HK)Innovent Biologics partners with Pfizer to further upgrade globalization-260602

上传日期：	2026/6/2	大小：	690KB
格式：	pdf 共10页	来源：	中信建投
评级：	--	作者：	--
下载权限：	此报告为加密报告

相关研报

中信建投-软件与服务：Reviewing AI evolution under the effective computing power framework_structural shifts in hardware and reshaping of cloud ecosystem patterns-260602
中信建投-Qfin Holdings(QFIN.O)Continued Proactive Optimization of Customer Mix Puts Near-term Pressure on Loan Origination Volume-260602
中信建投-Agora(API.O)1Q26 review,revenue growth rebounds significantly,watch AI progress in the second half and operating profit turning positive-260602
中信建投-盐津铺子(002847)E-commerce correction is nearing an end,with continued breakthroughs in blockbuster products expected-260602
中信建投-美图公司(01357.HK)Focusing on productivity applications,Agentic AI drives volume and price growth-260602
中信建投-BILI(BILI.O)1Q26 review_Traffic and advertising maintain high growth,margins stable,optimistic on incremental new games in 2H-260602
中信建投-翔宇医疗(688626)Revenue maintains growth trend,with increased investment in new businesses such as brain-computer interface-260529
中信建投-百润股份(002568)Business improvement kicks off,growth acceleration expected in 2026-260529
中信建投-FinVolution(FINV.N)Overseas revenue share stands firm at 30%,domestic risk improvement drives take rate increase-260529
中信建投-HESAI(HSAI.O)1Q26 Earnings Review_Profitability continues to be validated,secures Mercedes-Benz design win-260529

Copyright © 2005 - 2021 Nxny.com All Rights Reserved 备案号：蜀ICP备15031742号-1